Innovation in Fluxapyroxad Synthesis: Continuous Flow Technology Paving the Future
Release time:
2025-12-03
Source:
The most established industrial synthesis route for fluxapyroxad is the DFPC pathway, coupled with the Suzuki coupling-catalytic hydrogenation method for producing the key intermediate 3',4',5'-trifluoro-2-aminobiphenyl (TFBA). This route is characterized by concise steps, high yield (over 90% total yield), and minimal waste generation, making it highly suitable for large-scale production.
Ⅰ Fluxapyroxad: A Star Product in the Fungicide Market
Fluxapyroxad, a leading succinate dehydrogenase inhibitor (SDHI) fungicide developed by BASF, has held a critical position in the global fungicide market since its launch in 2012. It is widely used on crops such as grains and vegetables, effectively controlling over 20 diseases including brown spot and gray mold, thanks to its broad-spectrum and high-efficacy properties. According to literature data, fluxapyroxad achieved sales of $533 million in 2020, with peak annual sales expected to exceed €600 million. It has been registered in over 40 countries worldwide. With its compound patent expiring in 2026, the market is witnessing a surge in production, making efficient and low-cost synthesis processes a key competitive focus.
Ⅱ The Most Mature Industrial Route: DFPC Pathway & Synthesis of Key Intermediate TFBA
The most established industrial synthesis route for fluxapyroxad is the DFPC pathway, coupled with the Suzuki coupling-catalytic hydrogenation method for producing the key intermediate 3',4',5'-trifluoro-2-aminobiphenyl (TFBA). This route is characterized by concise steps, high yield (over 90% total yield), and minimal waste generation, making it highly suitable for large-scale production.
Reaction Pathway
The synthesis of fluxapyroxad consists of two main stages:
1.Synthesis of TFBA:
Starting from 3,4,5-trifluorobromobenzene, a Grignard reaction first generates 3,4,5-trifluorophenylmagnesium bromide, which is then reacted with a borate ester and hydrolyzed to yield 3,4,5-trifluorophenylboronic acid. Subsequent Suzuki coupling with 2-chloronitrobenzene forms 3',4',5'-trifluoro-2-nitrobi phenyl, followed by catalytic hydrogenation to produce TFBA.
Example Reaction Equations:

Figure 1 Roadmap for the synthesis of TFBA by Suzuki coupling catalytic hydrogenation method
2.Synthesis of Fluxapyroxad:
TFBA undergoes direct amidation with 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carbonyl chloride (DFPC) without the need for an acid scavenger, under mild conditions.
Reaction Equation:

3.Advantages of the Pathway
- High Yield and Purity: Total yield of TFBA synthesis exceeds 89%, with fluxapyroxad yield >90% and purity over 99%.
- Low Cost: Raw material 3,4,5-trifluorobromobenzene is readily available; DFPC can be derived from universal intermediates, offering significant economies of scale.
- Eco-Friendly and Safe: The acid-scavenger-free process reduces saline wastewater; catalytic hydrogenation is mild and avoids high-risk operations.
- Proven Technology: Well-documented in literature and applied in actual production, ideal for rapid industrialization post-patent expiration.
Ⅲ PMG Grignard Reactor: Empowering Synthesis of Key Intermediates
In TFBA synthesis, the Grignard reaction is a core step for constructing 3,4,5-trifluorophenylboronic acid. PMG Grignard reactor is optimized for such processes, offering the following advantages:
- Efficient Mass Transfer & Temperature Control: Microchannel design ensures rapid formation of Grignard reagents (e.g., 3,4,5-trifluorophenylmagnesium bromide), reducing reaction time by 50% and increasing yield to over 95%.
- Safe and Controllable: Real-time monitoring of parameters (temperature, pressure) avoids exothermic risks common in batch processes, ideal for handling flammable metal reagents.
- Seamless Continuous Flow Integration: Compatible with subsequent Suzuki coupling modules, enabling fully continuous production of TFBA and reducing intermediate separation steps.
- Case Support: Literature reports Grignard reaction yields exceeding 90% for TFBA synthesis; our reactor further optimizes conditions to support industrial-scale success.

Conclusion
The synthesis of fluxapyroxad is advancing toward greater efficiency and sustainability. The integration of the DFPC route with continuous flow technology will drive new momentum in the market. PMG Grignard reactor, with its safety and efficiency, is ideally suited for synthesizing key intermediates, helping customers capitalize on post-patent opportunities.
For custom process solutions or equipment inquiries, please contact us!
Other News